Abstract

Survival in the pediatric end-stage renal disease (ESRD) population has improved substantially over recent decades. Nonetheless, mortality remains at least 30 times higher than that of healthy peers. Patient survival is multifactorial and dependent on various patient and treatment characteristics and degree of economic welfare of the country in which a patient is treated. In this educational review, we aim to delineate current evidence regarding mortality risk in the pediatric ESRD population and provide pediatric nephrologists with up-to-date information required to counsel affected families
Original languageEnglish
Pages (from-to)585–594
JournalPediatric nephrology (Berlin, Germany)
Volume33
Issue number4
Early online date2017
DOIs
Publication statusPublished - 2018

Cite this